EVOTAZ

Product NDC

50090-1724

11-digit product format

500901724

Labeler code

50090

Product ID

50090-1724_126b39ae-83bc-4de8-95e3-2f6e33291f19

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

atazanavir and cobicistat

Dosage form

TABLET

Route

ORAL

Labeler

A-S Medication Solutions

Application

NDA206353

Marketing category

NDA

Marketing start

2015-01-29

Marketing end

0000-00-00

Substance

ATAZANAVIR SULFATE; COBICISTAT

Active strength

300 mg/1; mg/1

Pharmacologic classes

HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2019-12-31

Current FDA listing

Historical FDA.report record